載入...
Acute severe liver dysfunction induced by febuxostat in a patient undergoing hemodialysis
A 58-year-old man with chronic kidney disease (CKD) was admitted to our hospital for hemodialysis (HD) therapy. He had been administered allopurinol (100 mg/day) before hospitalization, and we replaced it with febuxostat (10 mg/day), a new xanthine oxidase inhibitor. Levels of aspartate aminotransfe...
Na minha lista:
| 發表在: | CEN Case Rep |
|---|---|
| Main Authors: | , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Springer Japan
2014
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5411563/ https://ncbi.nlm.nih.gov/pubmed/28509193 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13730-014-0109-2 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|